FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, namely to a method for preparing a pharmaceutical preparation for treating inflammatory intestinal diseases. The method for preparing a pharmaceutical preparation for oral administration for inflammatory intestinal diseases, particularly chronic inflammatory gastrointestinal diseases containing a storage-stable suspension of vital eggs of the parasitic, non-pathogenic to humans helminthes Trichuris suis, which involves preparing the suspension of helminth eggs in an acid at pH max. 2 at the first stage; at the following stage, the pH value is increased to min. 4, and a pharmacologically acceptable preserving agent is added. A pharmaceutical preparation for oral administration for inflammatory intestinal diseases, particularly chronic inflammatory intestinal diseases. The use of the pharmaceutical preparation for oral administration for inflammatory alimentary diseases, particularly chronic inflammatory alimentary diseases.
EFFECT: method enables more effective storage of the produced preparation of vital helminth eggs not accompanied by dangerous intergrowths of fungal spores and yeast propagation.
11 cl, 3 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION, CONTAINING PARASITE EGGS AND STORAGE OF PARASITE EGGS | 2006 |
|
RU2440818C2 |
METHOD OF DETERMINING BIOLOGICAL ACTIVITY OF EMBRYONATED EGGS OF TRICHURIS | 2009 |
|
RU2540145C2 |
DRUG WITH IMMUNOMODULATORY EFFECT | 2016 |
|
RU2629331C1 |
METHOD OF COLLECTING MAXIMUM AMOUNT OF MATURE (=FERTILIZED) EGGS (IN VITRO) OF FEMALES OF PARASITIC ZOONOSIS INFECTIOUS AGENT TRICHURIS (=TRICHOCEPHALUS) SUIS | 2015 |
|
RU2609145C2 |
LIFE-TIME DIAGNOSTIC TECHNIQUE FOR ZOONOSIS Trichocephalus trichiurus AND Trichocephalus suis BY EGG MICROSTRUCTURE | 2011 |
|
RU2464560C1 |
METHOD OF DUODENAL INTUBATION | 2022 |
|
RU2806154C1 |
METHOD OF OBTAINING AGENT FOR THE TREATMENT OF SOLID-HOOFED ANIMALS WITH PARASITOSIS | 2017 |
|
RU2681214C1 |
NEW AVIAN ASTROVIRUS | 2009 |
|
RU2547589C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING EYE DISEASES RELATED TO EYE TISSUE METABOLIC DISEASE AND INFLAMMATORY EYE TISSUE INJURY | 2013 |
|
RU2521337C1 |
METHOD FOR DIAGNOSIS OF HEMINTHIASIS CASE | 1996 |
|
RU2104534C1 |
Authors
Dates
2013-06-10—Published
2008-03-31—Filed